ahlam1399
04-02-2019, 09:10 PM
This immunotherapy combination shrinks rare, neuroendocrine: Study (https://www.thehealthsite.com/news/this-immunotherapy-combination-shrinks-rare-neuroendocrine-study/) TheHealthSiteAccording to a new study, after using a combination of ipilimumab (6 weeks) and nivolumab (2 weeks) the results showed that 42 per cent of patients with the ...
أكثر... (https://www.thehealthsite.com/news/this-immunotherapy-combination-shrinks-rare-neuroendocrine-study/)
أكثر... (https://www.thehealthsite.com/news/this-immunotherapy-combination-shrinks-rare-neuroendocrine-study/)